Somatic comorbidities among treated schizophrenic patients. Current recommendations;Comorbidités somatiques chez les patients souffrant de schizophrénie traitée. Recommandations actuelles

Annales Medico-Psychologiques

Volumn 164, Issue 2, 2006, Pages 159-164

  Lefebvre, N ^a   Chereau I ^a   Schmitt, A ^a   Llorca, P M ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERPROLACTINEMIA; NARCOLEPSY; PREVALENCE; PSYCHOSOMATIC DISORDER; REVIEW; SCHIZOPHRENIA;

EID: 33644963784     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amp.2005.11.006     Document Type: Article

References (25)

1. Allison The distribution of body mass index among individuals with or without schizophrenia J. Clin. Psychiatry 60 1999 215 220
2. M.A. Austin, J. Hokanson, and K. Edwards Hypertriglyceridemia as a cardiovascular risk factor Am. J. Cardiol. 81 1998 7B 12B
3. P. Batel Addiction and schizophrenia Eur. Psychiatry 15 2000 115 122
4. S.R. David, C.C. Taylor, B.J. Kinon, and A. Breier The effects of olanzapine, risṕridone and haloperidol on prolactin levels in patients with schizophrenia Clin. Ther. 22 2000 1085 1096
5. D.V. Jeste, J.A. Gladsjo, L.A. Lindamer, and J.P. Lacro Schizophr. Bull. 22 3 1996
6. L. Dixon, P. Weiden, and J. Delahanty Prevalence and correlates of diabetes in national schizophrenia samples Schizophr. Bull. 26 2000 903 912
7. D.C. Goff, C. Cather, E. Evins, D. Henderson, O. Freudenreich, and P. Copeland Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists J. Clin. Psychiatry 66 2005 183 194
8. A.R. Feinstein Clinical biostatistics. V. The architecture of clinical research (concluded) Clin. Pharmacol. Ther. 11 1970 755 771 (No abstract available)
9. T.P. George, J.C. Vessicchio, A. Termine, T.A. Bregartner, A. Feingold, and B.J. Rounsaville A placebo controlled trial of bupropion for smoking cessation in schizophrenia Biol. Psychiatry 52 2002 53 61
10. Glassman Cigarette smoking: Implications for psychiatric illness Am. J. Psychiatry 150 1993 546 553
11. Goff, Henderson, and Amico Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects Am. J. Psychiatry 149 1992 1189 1194
12. D. Henderson, E. Cagliero, and C. Gray Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five years naturalistic study Am. J. Psychiatry 157 2000 975 981
13. J. Hughes Prevalence of smoking among psychiatric outpatients Am. J. Psychiatry 143 1986 993 997
14. D.L. Kleinberg, J.M. Davis, R. de Coster, B. Van Baelen, and M. Brecher Prolactin levels and adverse events in patients treated with risperidone J. Clin. Psychopharmacol. 19 1999 57 61
15. E. Koller, B. Schneider, and L. Bennett Clozapine-associated diabetes Am. J. Med. 111 2001 716 723
16. C.E. Koro, D.O. Fedder, G.J. L'Italien, S. Weiss, L.S. Magder, and J. Kreyenbuhl An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients Arch. Gen. Psychiatry 59 2002 1021 1026
17. J. de Leon, F.J. Diaz, and T. Rogers Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders Schizophr. Res. 56 2002 47 54
18. S.R. Marder, S.M. Essock, A. Miller, R.W. Buchanan, D.E. Casey, and J.M. Davis Physical health monitoring of patients with schizophrenia Am. J. Psychiatry 161 2004 1334 1349
19. J.M. Meyer A retrospective comparison of weight, lipid, and glucose changes between risperidone and olanzapine treated inpatients: Metabolic outcomes after 1 year J. Clin. Psychiatry 63 2002 425 433
20. S.C. Newman, and R.C. Bland Mortality in a cohort of patients with schizophrenia: A record linkage study Can. J. Psychiatry 1991
21. A. Olincy, D.A. Young, and R. Freedman Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers Biol. Psychiatry 42 1997 1 5
22. P. Sunyer The obesity epidemic: Pathophysiology and consequences of obesity Obes. Res. 10 suppl2 2002 97S 104S
23. M.J. Sernyak, D.L. Leslie, R.D. Alarcon, M.F. Losonczy, and R. Rosenheck Association of diabetes mellitus with use of atypical antipsychotics in the treatment of schizophrenia Am. J. Psychiatry 159 2002 561 566
24. M. Susce, N. Villanueva, F. Diaz, and J. de Leon Obesity and associated complications in patients with severe mental illnesses: A cross-sectional survey J. Clin. Psychiatry 66 2005 167 173
25. Yassa Nicotine exposure and tardive dyskinesia Biol. Psychiatry 22 1987 67 72